VRNA - Verona Pharma Plc - ADR
IEX Last Trade
27.49
1.480 5.384%
Share volume: 1,225,274
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$26.01
1.48
5.69%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2022-05-03 | 2022-08-09 | 2022-11-09 | 2023-03-07 | 2023-05-09 | 2023-08-03 | 2023-11-02 | |
Cash flow financing | -726.000 K | -689.000 K | 139.619 M | 2.614 M | 68.685 M | 124.000 K | 48.000 K | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -14.512 M | -19.517 M | -18.095 M | -7.738 M | -5.782 M | -21.311 M | -12.727 M | |
Net income | -24.837 M | -17.766 M | -15.647 M | -10.451 M | -16.743 M | -8.807 M | -14.687 M | |
Depreciation | 163.000 K | 165.000 K | 157.000 K | 151.000 K | 157.000 K | 157.000 K | 155.000 K | |
Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 16.420 M | 20.185 M | 20.321 M | 9.282 M | 11.842 M | 10.150 M | 9.510 M | |
Investing Cashflow | 0.000 | -29.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net Borrowings | -130.847 M | -112.870 M | -232.305 M | -223.066 M | -274.525 M | -257.249 M | -246.716 M | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | 0.000 | -29.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash Change | 132.764 M | 111.510 M | 231.701 M | 227.827 M | 291.415 M | 270.727 M | 257.366 M |